The Washington Post on MSN5d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
News Nation on MSN6d
Weight loss drug Zepbound approved to help sleep apnea patients
( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...
Zepbound will dominate obesity market following SURMOUNT-5 results, says analyst
According to key opinion leaders, positive SURMOUNT-5 results, alongside Lilly’s business strategy, means Zepbound is set to ...
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...
WISH-TV on MSN3d
Lilly’s Zepbound approved by FDA for sleep apnea treatment
The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans ...
Onlymyhealth6d
FDA Approves Weight-Loss Drug Zepbound For Obstructive Sleep Apnea
Weight loss is a proven strategy to alleviate ... way for expanded insurance coverage for OSA-related treatments. Most side effects of Zepbound were mild to moderate gastrointestinal issues ...
Yahoo6d
Weight loss drug Zepbound approved to help sleep apnea patients
“For some patients who have sleep apnea, combining another treatment with Zepbound may be ideal,” the association says. “Furthermore, weight loss from Zepbound must be maintained over time ...
The Hill6d
FDA approves Zepbound for sleep apnea in obese adults
Sleep apnea causes people to stop and start breathing repeatedly Zepbound is first drug approved by FDA to help treat it Two studies found that those who used it saw reduction in apnea events ...
GLP-1 questions emerge for 2025
The weight-loss market began feeling some growing pains as the year ended, creating more wariness for the upcoming year. For ...